Monday, May 29, 2023 11:34:47 AM
This website you linked to just aggregates filings. It doesn't even try to be accurate with the information. Additionally, it is clearly lumping in all of Vera's MRKR and ALVR activity. They acknowledge this in one spot while ignoring it in others.
They are just pulling this from filings so it is purely based on Vera's MRKR and ALVR holdings. Highly inaccurate. Also, as of March 2021 so currently irrelevant.
He does not. He owns 267,183 worth ~$341,994.
He did not. He sold ALVR shares. He has sold $0 worth of MRKR unless you include his disposition of shares for tax purposes upon being granted a stock award in which case he has sold ~$16,228.
Again, no. One MRKR trade, the purchase, and four ALVR sales.
Would you look at that, a broken clock is right twice a day.
LOL. Again, no. Also, this information is worthless even if it was accurate.
Because I'm bored I'll list everything out as this website should have done to begin with.
All ownership numbers are split adjusted.
At the time of the merger on October 17th 2018 Vera was issued 199,305 shares and warrants to purchase an additional 72,278 shares at $29.90. The warrants expire in October of this year. (Form 3)
On October 19, 2018 he was issued 50,000 options exercisable at $91.80. Vesting over a four year period and expiring after 10 years. (Form 4)
On March 10, 2020 he was issued 14,000 options exercisable at $21.20. Vesting over a four year period and expiring after 10 years. (Form 4)
On February 10, 2021 he was issued 14,000 options exercisable at $32.90. Vesting over a four year period and expiring after 10 years. (Form 4)
On March 16, 2021 he purchased 57,142 shares at $17.50. (Form 4)
On February 17, 2022 he was issued 16,000 options exercisable at $4.60. Vesting over a four year period and expiring after 10 years. (Form 4)
On March 24, 2022 he was issued a stock award of 14,082 shares. He immediately "disposed" of 3,346 shares as payment of taxes owned on the stock award. (Form 4)
On February 27, 2023 he was issued 46,487 options exercisable at $2.14. Vesting over a four year period and expiring after 10 years. (Form 4)
On May 10, 2023 he was issued 100,000 options exercisable at $1.42 as he was appointed as President and CEO. Vesting over a four year period and expiring after 10 years. (Form 4)
Vera's total ownership:
267,183 shares
72,287 warrants at an exercise price of $29.90 expiring in October
240,487 options (not all currently vested) exercisable between $1.42 and $91.80
Just in the event I missed anything HERE are all of Vera's SEC filings.
My DD is not a substitute for your DD
Recent MRKR News
- Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:47:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:39:13 PM
- Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/14/2024 08:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:12:59 AM
- Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma • GlobeNewswire Inc. • 08/12/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:05:47 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 10:25:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:40:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:21 PM
- Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies • GlobeNewswire Inc. • 04/08/2024 11:00:39 AM
- Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results • GlobeNewswire Inc. • 03/25/2024 09:45:00 PM
- Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference • GlobeNewswire Inc. • 03/22/2024 04:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:58:51 PM
- Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601 • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:30:48 PM
- Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization • GlobeNewswire Inc. • 01/08/2024 01:24:49 PM
- Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024” • GlobeNewswire Inc. • 12/21/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:35:22 PM
- Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse • GlobeNewswire Inc. • 12/11/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:37:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:03:53 PM
- Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:53 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM